Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Study Commences For Patients With Two Relapsed/Refractory Blood Cancers 5/28/2015 7:26:28 AM
FDA Grants Fast Track Designation For IntelliPharmaCeutics Rexista Oxycodone XR Incorporating PODRAS Technology 5/26/2015 6:38:03 AM
Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial 5/18/2015 6:35:05 AM
AbbVie (ABBV) Receives Orphan Drug Designation For HUMIRA (Adalimumab) From The FDA For The Investigational Treatment Of Moderate-To-Severe Hidradenitis Suppurativa (HS) 5/15/2015 10:20:52 AM
Orexigen (OREX) Aborts Required Study For Diet Drug Contrave 5/12/2015 6:58:18 AM
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015 1:32:40 PM
Orexigen (OREX) Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals 5/13/2015 6:31:50 AM
Heart-Stopping Morning Leads to Vertex (VRTX) Rise As FDA News Sees Positives 5/8/2015 11:00:08 AM
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation By The Hemispherx Biopharma (HEB) For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 5/11/2015 7:53:27 AM
Bristol-Myers Squibb (BMY) Release: Long-Term, 7-Year Study Of Nulojix (Belatacept) Regimen Demonstrates Statistically Significant Relative Risk Reduction Of Death Or Graft Loss Over Cyclosporine Regimen In Kidney Transplant 5/6/2015 11:33:31 AM
Kowa Pharmaceuticals America Release: New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease 5/4/2015 6:28:35 AM
Bayer HealthCare (BAY) Release: Five-Year Follow-Up Study Further Supports Effectiveness And Safety Of The Essure Procedure As A Non-Surgical, Non-Hormonal Option For Permanent Contraception 5/1/2015 8:37:02 AM
Actavis (ACT) And Medicines360 Announce Publication Of ACCESS IUS Efficacy And Safety Study Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 mg in Contraception 4/29/2015 6:32:13 AM
Gilead (GILD) Offers Free Drugs in Georgia in Hep C Eradication Experiment 4/23/2015 6:20:21 AM
Effect Of Genzyme (GENZ)’s Multiple Sclerosis Treatment Lemtrada (Alemtuzumab) On Slowing Brain Atrophy And MRI Lesion Activity Maintained Through Four Years 4/23/2015 8:42:28 AM
1234567
//-->